Literature DB >> 23950038

Hypothalamic actions of apelin on energy metabolism: new insight on glucose homeostasis and metabolic disorders.

C Knauf1, A Drougard1, A Fournel1, T Duparc2, P Valet1.   

Abstract

Hypothalamus is key area implicated in control of glucose homeostasis. This structure integrates nervous and peripheral informations to adapt a response modifying peripheral glucose utilization and maintaining energetic balance. Among peripheral signals, adipokines such as adiponectin and leptin are of special importance since deregulations of their actions are closely associated to metabolic disorders such as obesity and type 2 diabetes. During the past ten years, we have identified a new adipokine named apelin which has emerging role in the control of metabolism. The originality of the apelinergic system is to be largely represented in peripheral tissues (adipose tissue, intestine, etc.) and in the brain. Then, apelin is released by adipose tissue as all adipokines, but also present another crucial role as neurotransmitter in hypothalamic neurons. By acting in the whole body, apelin exerts pleiotropic actions and is now considered as a major determinant of physiological functions. Besides its general beneficial effects on peripheral targets, central action of apelin remains still a matter of debate. In this review, we have made a parallel between peripheral vs. central actions of apelin in term of signalization and effects. Then, we have focused our attention on hypothalamic apelin and its potential role in glucose metabolism and associated pathologies. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23950038     DOI: 10.1055/s-0033-1351321

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

1.  Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.

Authors:  Christopher Taveau; Catherine Chollet; Ludovic Waeckel; Dorinne Desposito; Daniel G Bichet; Marie-Françoise Arthus; Christophe Magnan; Erwann Philippe; Valerie Paradis; Fabienne Foufelle; Isabelle Hainault; Sofia Enhorning; Gilberto Velho; Ronan Roussel; Lise Bankir; Olle Melander; Nadine Bouby
Journal:  Diabetologia       Date:  2015-01-27       Impact factor: 10.122

2.  Apelin-13 enhances arcuate POMC neuron activity via inhibiting M-current.

Authors:  Dong Kun Lee; Jae Hoon Jeong; Seunghoon Oh; Young-Hwan Jo
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 3.  Impact of hypothalamic reactive oxygen species in the regulation of energy metabolism and food intake.

Authors:  Anne Drougard; Audren Fournel; Philippe Valet; Claude Knauf
Journal:  Front Neurosci       Date:  2015-02-24       Impact factor: 4.677

4.  Editorial: Trends in Neuroendocrinology.

Authors:  Hubert Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-18       Impact factor: 5.555

5.  Vasopressin V1a receptors mediate the hypertensive effects of [Pyr1 ]apelin-13 in the rat rostral ventrolateral medulla.

Authors:  Philip R Griffiths; Stephen J Lolait; Louise E Harris; Julian F R Paton; Anne-Marie O'Carroll
Journal:  J Physiol       Date:  2017-04-21       Impact factor: 5.182

6.  Serum elabela and apelin levels during different stages of chronic kidney disease.

Authors:  Xuehong Lu; Shengmao Liu; Rumei Luan; Wenpeng Cui; Yu Chen; Yixian Zhang; Yue Lu; Hong Zhang; Lin Shi; Lining Miao; Feng Xu
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 7.  Apelin and energy metabolism.

Authors:  Chantal Bertrand; Philippe Valet; Isabelle Castan-Laurell
Journal:  Front Physiol       Date:  2015-04-10       Impact factor: 4.566

8.  Central chronic apelin infusion decreases energy expenditure and thermogenesis in mice.

Authors:  Anne Drougard; Audren Fournel; Alysson Marlin; Etienne Meunier; Anne Abot; Tereza Bautzova; Thibaut Duparc; Katie Louche; Aurelie Batut; Alexandre Lucas; Sophie Le-Gonidec; Jean Lesage; Xavier Fioramonti; Cedric Moro; Philippe Valet; Patrice D Cani; Claude Knauf
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.